Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov:157:518-519.
doi: 10.1016/j.ejca.2021.08.042. Epub 2021 Sep 24.

The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model

Alexander M M Eggermont  1 , Domenico Bellomo  2 , Jvalini Dwarkasing  2 , Lisette Meerstein-Kessel  2 , Alexander Meves  3
Affiliations
Comment

The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model

Alexander M M Eggermont et al. Eur J Cancer. 2021 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement Dr. Eggermont received honoraria from Actelion, Agenus, Bayer, Biocad, Biovent, BMS, CatalYm, CellDex, Ellipses, Forbion, Gilead, GSK, HalioDx, Incyte, IO Biotech, Isa Pharmaceuticals, MedImmune, Merck GmbH, MSD, Novartis, Pfizer, Polynoma, Regeneron, Sanofi, SkylineDx and Stellas over the past five years, has equity stakes in SkylineDx and Theranovir and speaker engagements with Biocad, MSD and Novartis. Dr. Bellomo has equity stakes in SkylineDx and Synlogic. Dr. Meerstein-Kessel and Dr. Dwarkasing have equity stakes in SkylineDx. Dr. Bellomo, Dr. Meerstein-Kessel, and Dr. Dwarkasing are employees of SkylineDx. Dr. Bellomo and Dr. Meves report patents pending for gene signatures for predicting melanoma metastasis.

Comment on

LinkOut - more resources